Cardiomyopathy Trial, Recruiting (NCT03586518)

Cardiomyopathy Trial, Recruiting NCT03586518 Sponsor: University of Leicester Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT03586518 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been receiving kidney dialysis (haemodialysis) for more than 3 months
You are on a supportive (palliative) care programme and doctors expect that you may pass away within the next 12 months
You are able to give your informed agreement to take part in the study
You are willing to agree for your heart to be donated for research purposes after you pass away
You are able to understand written and spoken information given in English

Who may not be able to join:

You have a reason why you cannot have an MRI scan, such as having a pacemaker, certain metal implants in your body, or severe claustrophobia (fear of enclosed spaces)
You have, or may have, a specific type of heart condition where abnormal substances build up in the heart muscle (for example, a condition called amyloidosis) (confirm with trial site)
You are not able to give your informed agreement to take part
You are not able to understand written or spoken information in English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: James Burton, DM, FRCP, Associate Professor in Renal Medicine

Phone: +44 (0)116 2588043

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03586518

Sponsor: University of Leicester

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +44 (0)116 2588043

More information: https://clinicaltrials.gov/study/NCT03586518

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been receiving kidney dialysis (haemodialysis) for more than 3 months
You are on a supportive (palliative) care programme and doctors expect that you may pass away within the next 12 months
You are able to give your informed agreement to take part in the study
You are willing to agree for your heart to be donated for research purposes after you pass away
You are able to understand written and spoken information given in English

Who may not be able to join:

You have a reason why you cannot have an MRI scan, such as having a pacemaker, certain metal implants in your body, or severe claustrophobia (fear of enclosed spaces)
You have, or may have, a specific type of heart condition where abnormal substances build up in the heart muscle (for example, a condition called amyloidosis) (confirm with trial site)
You are not able to give your informed agreement to take part
You are not able to understand written or spoken information in English

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Leicester

Registry

ClinicalTrials.gov

Start date

3 November 2019

Est. completion

31 December 2025

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Correlation between MRI and histological measures of cardiac fibrosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov